Pharmacotherapy for Anxiety Disorders in Children and Adolescents

Ian Kodish, Carol Rockhill, Sheryl Ryan, Chris Varley

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Anxiety disorders comprise the most prevalent mental health disorders among children and adults. Psychotherapy and pharmacotherapy are effective in improving clinical impairments from anxiety disorders and maintaining these improvements. This article discusses how to obtain a suitable diagnosis for anxiety disorders in youth for implementing appropriate treatments, focusing on the evidence base for pharmacologic treatment. Clinical guidelines are discussed, including Food and Drug Administration indications and off-label use of medications, and considerations for special populations and youth with comorbidities are highlighted. Findings suggest moderate effectiveness of medication, particularly selective serotonin reuptake inhibitors, in the treatment of anxiety disorders in youth.

Original languageEnglish (US)
Pages (from-to)55-72
Number of pages18
JournalPediatric Clinics of North America
Volume58
Issue number1
DOIs
StatePublished - Feb 1 2011

Fingerprint

Anxiety Disorders
Drug Therapy
Off-Label Use
Serotonin Uptake Inhibitors
United States Food and Drug Administration
Mental Disorders
Psychotherapy
Comorbidity
Mental Health
Therapeutics
Guidelines
Population

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Kodish, Ian ; Rockhill, Carol ; Ryan, Sheryl ; Varley, Chris. / Pharmacotherapy for Anxiety Disorders in Children and Adolescents. In: Pediatric Clinics of North America. 2011 ; Vol. 58, No. 1. pp. 55-72.
@article{e3941f57c22e412ea8f92fdb2a2a1f80,
title = "Pharmacotherapy for Anxiety Disorders in Children and Adolescents",
abstract = "Anxiety disorders comprise the most prevalent mental health disorders among children and adults. Psychotherapy and pharmacotherapy are effective in improving clinical impairments from anxiety disorders and maintaining these improvements. This article discusses how to obtain a suitable diagnosis for anxiety disorders in youth for implementing appropriate treatments, focusing on the evidence base for pharmacologic treatment. Clinical guidelines are discussed, including Food and Drug Administration indications and off-label use of medications, and considerations for special populations and youth with comorbidities are highlighted. Findings suggest moderate effectiveness of medication, particularly selective serotonin reuptake inhibitors, in the treatment of anxiety disorders in youth.",
author = "Ian Kodish and Carol Rockhill and Sheryl Ryan and Chris Varley",
year = "2011",
month = "2",
day = "1",
doi = "10.1016/j.pcl.2010.10.002",
language = "English (US)",
volume = "58",
pages = "55--72",
journal = "Pediatric Clinics of North America",
issn = "0031-3955",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Pharmacotherapy for Anxiety Disorders in Children and Adolescents. / Kodish, Ian; Rockhill, Carol; Ryan, Sheryl; Varley, Chris.

In: Pediatric Clinics of North America, Vol. 58, No. 1, 01.02.2011, p. 55-72.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pharmacotherapy for Anxiety Disorders in Children and Adolescents

AU - Kodish, Ian

AU - Rockhill, Carol

AU - Ryan, Sheryl

AU - Varley, Chris

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Anxiety disorders comprise the most prevalent mental health disorders among children and adults. Psychotherapy and pharmacotherapy are effective in improving clinical impairments from anxiety disorders and maintaining these improvements. This article discusses how to obtain a suitable diagnosis for anxiety disorders in youth for implementing appropriate treatments, focusing on the evidence base for pharmacologic treatment. Clinical guidelines are discussed, including Food and Drug Administration indications and off-label use of medications, and considerations for special populations and youth with comorbidities are highlighted. Findings suggest moderate effectiveness of medication, particularly selective serotonin reuptake inhibitors, in the treatment of anxiety disorders in youth.

AB - Anxiety disorders comprise the most prevalent mental health disorders among children and adults. Psychotherapy and pharmacotherapy are effective in improving clinical impairments from anxiety disorders and maintaining these improvements. This article discusses how to obtain a suitable diagnosis for anxiety disorders in youth for implementing appropriate treatments, focusing on the evidence base for pharmacologic treatment. Clinical guidelines are discussed, including Food and Drug Administration indications and off-label use of medications, and considerations for special populations and youth with comorbidities are highlighted. Findings suggest moderate effectiveness of medication, particularly selective serotonin reuptake inhibitors, in the treatment of anxiety disorders in youth.

UR - http://www.scopus.com/inward/record.url?scp=79251564441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251564441&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2010.10.002

DO - 10.1016/j.pcl.2010.10.002

M3 - Review article

C2 - 21281848

AN - SCOPUS:79251564441

VL - 58

SP - 55

EP - 72

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

SN - 0031-3955

IS - 1

ER -